StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Soligenix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Soligenix's enterprise value was -$2.86M on Nov 11, 2026, against $5.15M a year earlier. Over the last 5 years it ranged from -$8.88M to $14.92M, with a median of -$2.10M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$2.86M-206.3%
2025Dec 31, 2025$2.69M–
2024Dec 31, 2024-$3.65M–
2023Dec 29, 2023-$2.44M-196.4%
2022Dec 30, 2022$2.53M–
2021Dec 31, 2021-$719.98K-102.7%
2020Dec 31, 2020$27.02M+40.9%
2019Dec 31, 2019$19.17M+449.9%
2018Dec 31, 2018$3.49M-57.2%
2017Dec 29, 2017$8.15M+191.8%
2016Dec 30, 2016$2.79M-89.5%
2015Dec 31, 2015$26.55M+52.6%
2014Dec 31, 2014$17.40M-37.6%
2013Dec 31, 2013$27.89M+830.4%
2012Dec 31, 2012$3.00M-97.6%
2011Dec 30, 2011$125.37M–

More Soligenix figures

See a number that looks wrong?